{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:02:39Z","timestamp":1792512159014,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1053\/j.semdp.2020.08.003","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T13:23:47Z","timestamp":1600349027000},"page":"199-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["SWI\/SNF-deficient malignancies of the female genital tract"],"prefix":"10.1053","volume":"38","author":[{"given":"W. Glenn","family":"McCluggage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.R.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1053\/j.semdp.2020.08.003_bib0001","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41556-018-0221-1","article-title":"A non-canonical SWI\/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation","volume":"20","author":"Michel","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0002","unstructured":"Witkowski L., Huang S., Foulkes W.D. SWI\/SNF complex disorders: pathobiology, mechanisms and therapeutic opportunities, 2018."},{"key":"10.1053\/j.semdp.2020.08.003_bib0003","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pathol.2017.10.006","article-title":"Endometriosis-associated ovarian neoplasia","volume":"50","author":"Matias-Guiu","year":"2018","journal-title":"Pathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0004","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/or.2015.4421","article-title":"ARID1A gene mutation in ovarian and endometrial cancers (Review)","volume":"35","author":"Takeda","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1053\/j.semdp.2020.08.003_bib0006","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3802\/jgo.2013.24.4.376","article-title":"The roles of ARID1A in gynecologic cancer","volume":"24","author":"Mao","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0007","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAP.0b013e31827bc24d","article-title":"Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms","volume":"20","author":"Maeda","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0008","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/PGP.0b013e31823f8482","article-title":"Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A","volume":"31","author":"Wu","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0009","article-title":"DICER1-associated sarcomas: towards a unified nomenclature","author":"McCluggage","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0010","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.pas.0000171003.72352.9a","article-title":"Undifferentiated carcinoma of the endometrium","volume":"29","author":"Altrabulsi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0011","series-title":"WHO Classification of Tumours of Female Reproductive Organs","first-page":"121","article-title":"Tumours of the uterine corpus","author":"Zaino","year":"2014"},{"key":"10.1053\/j.semdp.2020.08.003_bib0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pgp.0000183048.22588.18","article-title":"Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?","volume":"25","author":"Silva","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0013","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.2010.41","article-title":"Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms","volume":"23","author":"Tafe","year":"2010","journal-title":"Mod. Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0014","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","article-title":"SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"47","author":"Stewart","year":"2015","journal-title":"Pathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/01443615.2014.958441","article-title":"Undifferentiated uterine carcinoma: analysis of eighteen cases","volume":"35","author":"Ureyen","year":"2015","journal-title":"J Obstet Gynaecol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0016","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5858\/arpa.2011-0461-RS","article-title":"Undifferentiated endometrial carcinoma. A diagnosis frequently overlooked","volume":"137","author":"Al-Loh","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2020.08.003_bib0017","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/00313020601159494","article-title":"Undifferentiated carcinoma of the endometrium: a review","volume":"39","author":"Silva","year":"2007","journal-title":"Pathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0018","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cas.12065","article-title":"Lung cancer with loss of BRG1\/BRM, shows an epithelial mesenchymal transition phenotype and distinct histologic and genetic features","volume":"104","author":"Matsubara","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2020.08.003_bib0019","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0000000000000038","article-title":"The expanding family of SMARCB1 (INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity","volume":"21","author":"Agaimy","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PGP.0000000000000248","article-title":"Undifferentiated carcinoma of the endometrium: an expanded immunohistochemical analysis including PAX-8 and basal-like carcinoma surrogate markers","volume":"35","author":"Ramalingam","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0021","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/his.12989","article-title":"Immunophenotypic features of dedifferentiated endometrial carcinoma- insights from BRG1\/INI1-deficient tumours","volume":"69","author":"Hoang","year":"2016","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0022","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2016.156","article-title":"Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas","volume":"29","author":"Coatham","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0023","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/modpathol.2013.93","article-title":"ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma","volume":"26","author":"Romero-Perez","year":"2013","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2020.08.003_bib0024","article-title":"High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated\/ dedifferentiated carcinomas of the endometrium","volume":"96","author":"Onder","year":"2017","journal-title":"An immunohistochemical and clinicopathologic study. Medicine"},{"key":"10.1053\/j.semdp.2020.08.003_bib0025","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.humpath.2015.06.011","article-title":"Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"46","author":"Stewart","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1097\/00125480-200405000-00004","article-title":"A critical appraisal of the value of immunohistochemistry in diagnosis of uterine neoplasms","volume":"11","author":"McCluggage","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0027","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/his.12057","article-title":"Epithelial-mesenchymal transition in carcinomas of the female genital tract","volume":"62","author":"Stewart","year":"2013","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0028","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/pin.12557","article-title":"Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: a case report","volume":"67","author":"Lee","year":"2017","journal-title":"Pathol Int"},{"key":"10.1053\/j.semdp.2020.08.003_bib0029","doi-asserted-by":"crossref","unstructured":"Busca A., Parra-Herran C., Nofech-Mozes S., et\u00a0al. Undifferentiated Endometrial Carcinoma Arising in the Background of High-Grade Endometrial Carcinoma \u2013 Expanding the Definition of Dedifferentiated Endometrial Carcinoma. Histopathology. 2020 Jun 18. doi: 10.1111\/his.14186. Online ahead of print.","DOI":"10.1111\/his.14186"},{"key":"10.1053\/j.semdp.2020.08.003_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PGP.0000000000000584","article-title":"Dedifferentiated carcinoma of the endometrium associated with low-grade Mullerian adenosarcoma: a clinicopathologic case report including the immunohistochemical and molecular profile","volume":"39","author":"Bai","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0031","article-title":"Sarcomatous Transformation in Undifferentiated\/Dedifferentiated Endometrial Carcinoma: an Underrecognized Phenomenon and Diagnostic Pitfall","author":"Vroobel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0032","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/ rhabdoid carcinomas of the gastrointestinal tract. A series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent coinactivation of SMARCB1 and SMARCA2","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0033","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0034","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/his.13091","article-title":"Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology","volume":"70","author":"Ramalingam","year":"2017","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.04.001","article-title":"Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant","volume":"19","author":"Strehl","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0036","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PAS.0000000000000941","article-title":"Undifferentiated endometrial carcinomas show frequent loss of core switch\/ sucrose nonfermentable complex proteins","volume":"42","author":"Kobel","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0037","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","article-title":"Mutation and loss of expression of ARID1A in uterine low grade endometrioid carcinoma","volume":"35","author":"Guan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0038","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/path.2911","article-title":"Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas","volume":"224","author":"Wiegland","year":"2011","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0039","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.4633","article-title":"Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type","volume":"238","author":"Karnezis","year":"2016","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1111\/his.13525","article-title":"Frequent loss of cludin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas","author":"Tessier-Cloutier","year":"2018","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0041","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/modpathol.2016.230","article-title":"Claudin-4 expression distinguishes SWI\/SNF complex-deficient undifferentiated carcinomas from sarcomas","volume":"30","author":"Schaefer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0042","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/PAS.0000000000000427","article-title":"Cyclin D1 does not distinguish YWHAE-NUTM2 high-grade endometrial stromal sarcoma from undifferentiated endometrial carcinoma","volume":"39","author":"Shah","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0043","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/his.13019","article-title":"CD34 expression in undifferentiated endometrial carcinoma","volume":"69","author":"Shah","year":"2016","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0044","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PGP.0b013e318223118a","article-title":"p16ink4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin","volume":"31","author":"Saad","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0045","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/PAS.0000000000000166","article-title":"Molecular characterization of undifferentiated carcinoma associated with endometrioid carcinoma","volume":"38","author":"Kuhn","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0046","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/PAS.0000000000000873","article-title":"Undifferentiated and dedifferentiated endometrial carcinomas with POLE exonuclease domain mutations have a favourable prognosis","volume":"41","author":"Espinosa","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0047","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PGP.0b013e3181895539","article-title":"The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium","volume":"28","author":"Taraif","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0048","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.humpath.2017.11.006","article-title":"Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study","volume":"72","author":"Espinosa","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0049","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","article-title":"Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases","volume":"40","author":"Pocrnich","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0050","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/modpathol.2016.132","article-title":"Molecular genetic heterogeneity in undifferentiated endometrial carcinomas","volume":"29","author":"Rosa-Rosa","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0051","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2020.08.003_bib0052","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","article-title":"SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma","volume":"31","author":"Kolin","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0053","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma are Distinct Clinicopathologic Entities","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0054","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41379-019-0303-z","article-title":"SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association","volume":"32","author":"Lin","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.humpath.2006.12.003","article-title":"Mutation of INI1 gene in composite rhabdoid tumor of the endometrium","volume":"38","author":"Donner","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0056","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2559.2010.03738.x","article-title":"Proximal-type epithelioid sarcoma of the uterine corpus","volume":"58","author":"Venizelos","year":"2011","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0057","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00004347-199910000-00017","article-title":"Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: a case report and review of the literature","volume":"18","author":"Gaertner","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0058","first-page":"236","article-title":"Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor","volume":"27","author":"Al-Hussaini","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0059","article-title":"Tumors of the ovary and maldeveloped gonads","volume":"16","author":"Scully","year":"1979"},{"key":"10.1053\/j.semdp.2020.08.003_bib0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1097-0142(19820101)49:1<188::AID-CNCR2820490137>3.0.CO;2-D","article-title":"Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases","volume":"49","author":"Dickersin","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2020.08.003_bib0061","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small-cell carcinoma of the ovary, hypercalcaemic type \u2013 a clinicopathological analysis of 150 cases","volume":"18","author":"Young","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0062","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.semdp.2014.08.001","article-title":"Ovarian tumors and tumor-like lesions in the first three decades","volume":"31","author":"Young","year":"2014","journal-title":"Sem Diagn Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0063","first-page":"523","article-title":"Familial occurrence of small cell carcinoma of the ovary","volume":"119","author":"Lamovec","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2020.08.003_bib0064","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jmg.33.4.333","article-title":"Familial cluster of ovarian small cell carcinoma. A new mendelian entity?","volume":"33","author":"Longy","year":"1998","journal-title":"J Med Genet"},{"key":"10.1053\/j.semdp.2020.08.003_bib0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ygyno.2016.03.013","article-title":"The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type","volume":"141","author":"Witkowski","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0066","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0046-8177(87)80336-2","article-title":"Poorly differentiated (small cell) carcinoma of the ovary in young women: evidence supporting a germ cell origin","volume":"18","author":"Ulbright","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0067","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/his.13177","article-title":"Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm","volume":"70","author":"McCluggage","year":"2017","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0068","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5114\/pjp.2013.39331","article-title":"Ovarian small-cell carcinoma of hypercalcemic type \u2013 evidence of germline origin and SMARCA4 gene inactivation. a pilot study","volume":"64","author":"Kupryjanczyk","year":"2013","journal-title":"Polish J. Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0069","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1525-1438.1998.09774.x","article-title":"A non-diploid small-cell carcinoma of the ovary of the hypercalcemic type","volume":"8","author":"Meganck","year":"1998","journal-title":"Int J Gynecol Cancer"},{"key":"10.1053\/j.semdp.2020.08.003_bib0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.pgp.0000139644.38835.9d","article-title":"An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type","volume":"23","author":"McCluggage","year":"2004","journal-title":"Int J Gynecol Pathol"},{"issue":"17","key":"10.1053\/j.semdp.2020.08.003_bib0071","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00004347-199801000-00009","article-title":"Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas","author":"Riopel","year":"1998","journal-title":"Int J Gynecol Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0072","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ajcp\/92.2.140","article-title":"Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings","volume":"92","author":"Aguirre","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0073","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/gyno.1995.0023","article-title":"Small cell carcinoma of the ovary of the hypercalcemic type: p53 protein accumulation and clinicopathologic features","volume":"59","author":"Seidman","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0074","first-page":"1878","article-title":"Human parathyroid hormone-related protein in ovarian small cell carcinoma","volume":"73","author":"Matias-Guiu","year":"1994","journal-title":"An immunohistochemical study. Cancer"},{"key":"10.1053\/j.semdp.2020.08.003_bib0075","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","article-title":"SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas","volume":"39","author":"Karanian-Philippe","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0076","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/PAS.0000000000000558","article-title":"Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small-cell carcinoma of ovary, hypercalcemic type","volume":"40","author":"Conlon","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0077","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/his.12988","article-title":"Loss of SMARCA4 (BRG1) protein expression by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcemic type distinguishes these tumours from their mimics","volume":"69","author":"Clarke","year":"2016","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2020.08.003_bib0078","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1053\/j.semdp.2020.08.003_bib0079","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small Cell Carcinoma of the Ovary, Hypercalcaemic Type - genetics, new treatment targets and current management guidelines","author":"Tischkowitz","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2020.08.003_bib0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1053\/j.semdp.2020.08.003_bib0081","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1053\/j.semdp.2020.08.003_bib0082","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.path.2016.01.005","article-title":"Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): a Review with Recent Developments on Pathogenesis","volume":"9","author":"Witkowski","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"10.1053\/j.semdp.2020.08.003_bib0083","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.4362","article-title":"No small surprise- small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour","volume":"233","author":"Foulkes","year":"2014","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0084","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gore.2015.02.002","article-title":"Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type","volume":"12","author":"Berchuck","year":"2015","journal-title":"Gynecol Oncol Reports"},{"key":"10.1053\/j.semdp.2020.08.003_bib0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gore.2019.02.002","article-title":"The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type","volume":"28","author":"Pejovic","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"10.1053\/j.semdp.2020.08.003_bib0086","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.pap.0000138146.357376.1e","article-title":"Ovarian neoplasms composed of small round cells: a review","volume":"11","author":"McCluggage","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0087","doi-asserted-by":"crossref","unstructured":"Chaudet K., Kem M., Lerwill M., et\u00a0al. SWI\/SNF protein and claudin-4 expression in anaplastic carcinomas arising in mucinous tumors of the ovary. Histopathology. 2020 Apr 8. doi: 10.1111\/his.14110. Online ahead of print.","DOI":"10.1111\/his.14110"},{"key":"10.1053\/j.semdp.2020.08.003_bib0088","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/PAS.0000000000000397","article-title":"SMARCB1-deficient vulvar neoplasms: a clinicopathologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"39","author":"Folpe","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0089","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.humpath.2009.04.025","article-title":"Myoepithelial neoplasms involving the vulva and vagina: report of 4 cases","volume":"40","author":"Meenakshi","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0090","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","article-title":"INI1-deficient tumors: diagnostic features and molecular genetics","volume":"35","author":"Hollmann","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0091","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/DAD.0b013e31818a5c4f","article-title":"INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics","volume":"31","author":"Orrock","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0092","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/PAS.0b013e3181882c54","article-title":"Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma","volume":"33","author":"Hornick","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0093","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1158\/0008-5472.CAN-04-3050","article-title":"SMARCB1\/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas","volume":"65","author":"Modena","year":"2005","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2020.08.003_bib0094","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/PAS.0000000000000466","article-title":"Myoepithelioma-like Tumors of the Vulvar Region: a Distinctive Group of SMARCB1-deficient Neoplasms","volume":"39","author":"Yoshida","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2020.08.003_bib0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.anndiagpath.2011.04.002","article-title":"Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility","volume":"16","author":"Kim","year":"2012","journal-title":"Ann Diagn Pathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257020300769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257020300769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:21:59Z","timestamp":1760037719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257020300769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0740257020300769"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2020.08.003","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SWI\/SNF-deficient malignancies of the female genital tract","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2020.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}